Literature DB >> 19659517

Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.

Blandine Rammaert1, Nicolas Verdier, Béatrice Cavestri, Saad Nseir.   

Abstract

BACKGROUND AND
OBJECTIVE: Little is known about the value of procalcitonin in predicting mortality in patients with an exacerbation of COPD. This study evaluated the clinical and biological predictors of intensive care unit (ICU) mortality in patients with a severe acute exacerbation of COPD.
METHODS: A prospective observational cohort study was conducted of consecutive patients with severe acute exacerbation of COPD requiring intubation and mechanical ventilation. At ICU admission, data were collected on the patients' clinical condition, blood leukocyte count, C-reactive protein and procalcitonin. Cox proportional hazards model was used to determine the risk factors for ICU mortality.
RESULTS: One hundred and sixteen patients were included in this study. Mean age was 67 years. The mean simplified acute physiology score was 43. Sixty-five per cent of study patients had chronic respiratory insufficiency. Bacteria were cultured at levels considered significant in 36% of study patients. Logistic organ dysfunction score (hazard ratio (95% CI) = 1.19 (1.03-1.37), P = 0.013), rapidly fatal underlying disease (3.33 (1.40-7.87), P = 0.003) and procalcitonin level (1.01 (1-1.03), P = 0.018) were independently associated with increased risk for ICU mortality. Non-invasive mechanical ventilation use before intubation was independently associated with reduced risk for ICU mortality (0.34 (0.14-0.84), P = 0.020).
CONCLUSIONS: In patients with severe acute exacerbation of COPD requiring intubation and mechanical ventilation, logistic organ dysfunction score, rapidly fatal underlying disease and procalcitonin are independently associated with increased risk for ICU mortality. Non-invasive mechanical ventilation use before intubation was independently associated with reduced risk for ICU mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659517     DOI: 10.1111/j.1440-1843.2009.01597.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  18 in total

1.  [Antimicrobial treatment of patients with severe acute exacerbation of COPD].

Authors:  B Klapdor; S Ewig
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-22       Impact factor: 0.840

2.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

4.  Interrelationship between procalcitonin and organ failure in sepsis.

Authors:  Dimple Anand; Sabari Das; Sumit Ray; Seema Bhargava; Lalit Mohan Srivastava
Journal:  Indian J Clin Biochem       Date:  2013-04-23

Review 5.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

6.  Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?

Authors:  Ahmet Cemal Pazarli; Handan Inonu Koseoglu; Sibel Doruk; Semsettin Sahin; Ilker Etikan; Serhat Celikel; Bahadir Berktas
Journal:  J Res Med Sci       Date:  2012-11       Impact factor: 1.852

7.  Prognostic value of serum growth differentiation factor-15 in patients with chronic obstructive pulmonary disease exacerbation.

Authors:  Miyoung Kim; Seung-Ick Cha; Keum-Ju Choi; Kyung-Min Shin; Jae-Kwang Lim; Seung-Soo Yoo; Jaehee Lee; Shin-Yup Lee; Chang-Ho Kim; Jae-Yong Park; Dong Heon Yang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-12-31

8.  How do COPD comorbidities affect ICU outcomes?

Authors:  Esra Akkutuk Ongel; Zuhal Karakurt; Cuneyt Salturk; Huriye Berk Takir; Bunyamin Burunsuzoglu; Feyza Kargin; Gulbanu H Ekinci; Ozlem Mocin; Gokay Gungor; Nalan Adiguzel; Adnan Yilmaz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-17

Review 9.  Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections.

Authors:  Vandack Nobre; Isabela Borges
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

10.  Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.

Authors:  Tao Zhang; Yan Wang; Qianting Yang; Yalin Dong
Journal:  BMC Infect Dis       Date:  2017-07-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.